Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for TGA Method for Moisture and Volatile Content – V 2.0

Posted on By

Analytical Method Development: SOP for TGA Method for Moisture and Volatile Content – V 2.0

Standard Operating Procedure for TGA Method Development for Moisture and Volatile Content Analysis


Department Analytical Method Development
SOP No. SOP/AMD/173/2025
Supersedes SOP/AMD/173/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

To describe the procedure for the development and validation of Thermogravimetric Analysis (TGA) methods to quantitatively determine moisture content, volatile solvents, and decomposition profiles in

pharmaceutical materials including APIs, excipients, and finished products.

2. Scope

This SOP applies to the Analytical Method Development (AMD) department for evaluating material stability, hygroscopicity, and thermal degradation using TGA instrumentation in R&D and routine analysis.

3. Responsibilities

  • Analytical Scientist: Responsible for method design, thermal profile evaluation, and interpretation.
  • Instrument Analyst: Operates and maintains the TGA instrument, performs calibration and sample runs.
  • QA Officer: Ensures review and compliance of validation reports and experimental data.
  • Head – AMD: Approves the developed TGA method and validates its implementation in QC or stability labs.
See also  Analytical Method Development: SOP for Robustness Evaluation in Analytical Method Validation - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring that all TGA methods are scientifically sound, validated, and aligned with ICH and pharmacopoeial standards.

5. Procedure

5.1 Instrument Setup and Calibration

  1. Ensure the TGA instrument is calibrated for temperature and weight using certified standards (e.g., calcium oxalate monohydrate).
  2. Document calibration data in Annexure-1: TGA Calibration Log.
  3. Verify purge gas (e.g., nitrogen or air) is connected and pressure is stable at 50–60 mL/min.

5.2 Sample Preparation

  1. Weigh 5–10 mg of powdered sample using an analytical balance.
  2. Use pre-tared, clean platinum or alumina crucibles with lids if applicable.
  3. Avoid contact with moisture prior to measurement; store hygroscopic samples in desiccators until analysis.

5.3 Method Parameters for Moisture and Volatile Analysis

  1. Set temperature program:
    • Start Temp: 25°C
    • End Temp: 150–300°C (depending on analyte)
    • Ramp Rate: 10°C/min
  2. Use isothermal holds at 105°C for accurate moisture quantification if needed.
  3. Record weight loss and derivative thermogravimetric (DTG) curves.
  4. Determine:
    • % Moisture (loss below 120°C)
    • % Volatile (loss between 120°C–200°C)
    • Thermal degradation (onset temperature)
  5. Enter all thermal transitions in Annexure-2: TGA Profile Report.
See also  Analytical Method Development: SOP for Thermal Degradation Study Method Development - V 2.0

5.4 Method Validation

  1. Validate TGA method per ICH Q2(R2) guidelines:
    • Precision – Repeatability of % loss (RSD ≤ 3%)
    • Accuracy – Recovery studies with known spiked water or solvent samples
    • Specificity – Ability to distinguish moisture from solvents
    • Robustness – Evaluate different ramp rates or crucible types
  2. Document validation summary in Annexure-3: Validation Log.

5.5 Safety Considerations

  1. Ensure the crucibles are cool before removing from furnace.
  2. Handle decomposing samples in fume hood if toxic gases are expected.
  3. Dispose of thermally decomposed residues as per hazardous waste policy.

6. Abbreviations

  • TGA: Thermogravimetric Analysis
  • DTG: Derivative Thermogravimetry
  • RSD: Relative Standard Deviation
  • ICH: International Council for Harmonisation
  • SOP: Standard Operating Procedure
See also  Analytical Method Development: SOP for Dissolution Method for Delayed Release Tablets - V 2.0

7. Documents

  1. TGA Calibration Log – Annexure-1
  2. TGA Profile Report – Annexure-2
  3. Validation Log – Annexure-3

8. References

  • ICH Q2(R2) – Validation of Analytical Procedures
  • USP <891> – Thermal Analysis
  • European Pharmacopoeia 2.2.34 – Thermogravimetric Analysis

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: TGA Calibration Log

Material Theoretical Temp (°C) Observed Temp (°C) Weight Loss (%) Analyst
Calcium Oxalate 133 132.8 18.5 Rajesh Kumar

Annexure-2: TGA Profile Report

Sample ID Moisture (%) Volatile (%) Decomposition Onset (°C) Analyst
API-TGA-22 2.1 3.5 218.6 Sunita Reddy

Annexure-3: Validation Log

Parameter Result Acceptance Criteria Status
Repeatability RSD = 2.4% ≤ 3% Pass
Accuracy 98.8% 95%–105% Pass

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Added DTG interpretation and expanded volatile content reporting Annual SOP Review
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Deviation Management in Quality Assurance – V 2.0
Next Post: Elixir Department: SOP for Operation of Transfer Pumps – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version